Failure of anakinra treatment of pyoderma gangrenosum in an IBD patient and relevance to the PSTPIP1 gene
Authors:
Open Access
- 1 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 17 (6) , E41-E42
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinraBritish Journal of Dermatology, 2009
- Longest Form of CCTG Microsatellite Repeat in the Promoter of the CD2BP1/PSTPIP1 Gene Is Associated with Aseptic Abscesses and with Crohn Disease in French PatientsDigestive Diseases and Sciences, 2009
- Saccharomyces cerevisiae Ebs1p is a putative ortholog of human Smg7 and promotes nonsense-mediated mRNA decayNucleic Acids Research, 2007
- Analysis of the NOD2/CARD15 Gene in Patients Affected with the Aseptic Abscesses Syndrome with or without Inflammatory Bowel DiseaseDigestive Diseases and Sciences, 2007
- Suppression and Overexpression of Adenosylhomocysteine Hydrolase-like Protein 1 (AHCYL1) Influences Zebrafish Embryo DevelopmentJournal of Biological Chemistry, 2006
- Molecular characterisation of the t(1;15)(p22;q22) translocation in the prostate cancer cell line LNCaPCytogenetic and Genome Research, 2005
- Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorderHuman Molecular Genetics, 2002
- A New Autosomal Dominant Disorder of Pyogenic Sterile Arthritis, Pyoderma Gangrenosum, and Acne: PAPA SyndromeMayo Clinic Proceedings, 1997